DE102007026341A1
(de)
|
2007-06-06 |
2008-12-11 |
Merck Patent Gmbh |
Benzoxazolonderivate
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
DE102007061963A1
(de)
|
2007-12-21 |
2009-06-25 |
Merck Patent Gmbh |
Pyridazinonderivate
|
WO2009099982A1
(en)
|
2008-02-04 |
2009-08-13 |
Osi Pharmaceuticals, Inc. |
2-aminopyridine kinase inhibitors
|
CN101998959B
(zh)
*
|
2008-02-06 |
2013-08-28 |
生物马林药物股份有限公司 |
聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂
|
AR070317A1
(es)
|
2008-02-06 |
2010-03-31 |
Osi Pharm Inc |
Furo (3,2-c) piridina y tieno (3,2-c) piridinas
|
DE102008019907A1
(de)
|
2008-04-21 |
2009-10-22 |
Merck Patent Gmbh |
Pyridazinonderivate
|
DE102008028905A1
(de)
|
2008-06-18 |
2009-12-24 |
Merck Patent Gmbh |
3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
|
WO2010054398A1
(en)
|
2008-11-10 |
2010-05-14 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
TWI396689B
(zh)
|
2008-11-14 |
2013-05-21 |
Amgen Inc |
作為磷酸二酯酶10抑制劑之吡衍生物
|
AR074411A1
(es)
*
|
2008-12-02 |
2011-01-12 |
Du Pont |
Compuestos heterociclicos fungicidas
|
EP2376485B1
(en)
|
2008-12-19 |
2017-12-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazine derivatives useful as inhibitors of atr kinase
|
PL2361250T3
(pl)
|
2008-12-22 |
2014-01-31 |
Merck Patent Gmbh |
Nowe polimorficzne formy diwodorofosforanu 6-(1-metylo-1H-pirazolo-4-ylo)-2-{3-[5-(2-morfolino-4-ylo-etoksy)-pirymidyno-2-ylo]-benzylo}2H-pirydazyno-3-onowego oraz sposoby ich otrzymywania
|
DE102009033208A1
(de)
|
2009-07-15 |
2011-01-20 |
Merck Patent Gmbh |
Aminopyridinderivate
|
UY33027A
(es)
*
|
2009-11-13 |
2011-06-30 |
Astrazeneca Ab |
Pirazina sustituida con oxazolo[4,5-c]piridina
|
MX2012013081A
(es)
|
2010-05-12 |
2013-05-09 |
Vertex Pharma |
Compuestos utiles como inhibidores de cinasa atr.
|
WO2011143425A2
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2569289A1
(en)
*
|
2010-05-12 |
2013-03-20 |
Vertex Pharmaceuticals Incorporated |
Pyrazines useful as inhibitors of atr kinase
|
WO2011143423A2
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
JP2013526538A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
NZ603478A
(en)
|
2010-05-12 |
2014-09-26 |
Vertex Pharma |
2 -aminopyridine derivatives useful as inhibitors of atr kinase
|
UY33452A
(es)
|
2010-06-16 |
2012-01-31 |
Bayer Schering Pharma Ag |
Triazolopiridinas sustituidas
|
EP2585468A1
(en)
|
2010-06-23 |
2013-05-01 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase
|
US20130315895A1
(en)
|
2010-07-01 |
2013-11-28 |
Takeda Pharmaceutical Company Limited |
COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
WO2012121939A2
(en)
*
|
2011-03-04 |
2012-09-13 |
Locus Pharmaceuticals, Inc. |
Aminopyrazine compounds
|
CN102718745A
(zh)
*
|
2011-03-30 |
2012-10-10 |
中国科学院上海药物研究所 |
新型胺基吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途
|
WO2012138809A1
(en)
*
|
2011-04-05 |
2012-10-11 |
Dawei Zhang |
Heterocyclic compounds as kinase inhibitors
|
WO2012138938A1
(en)
|
2011-04-05 |
2012-10-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazine compounds useful as inhibitors of tra kinase
|
AU2012259335B2
(en)
|
2011-05-23 |
2017-03-16 |
Merck Patent Gmbh |
Thiazole derivatives
|
MX352975B
(es)
|
2011-05-23 |
2017-12-15 |
Merck Patent Gmbh |
Piridina y derivados de pirazina.
|
US9309250B2
(en)
|
2011-06-22 |
2016-04-12 |
Vertex Pharmaceuticals Incorporated |
Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
|
EP2723745A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
EP2723747A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
CN103732588B
(zh)
*
|
2011-07-27 |
2016-10-12 |
南京奥昭生物科技有限公司 |
螺环分子作为蛋白激酶抑制剂
|
DE102011112978A1
(de)
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
ES2751741T3
(es)
|
2011-09-30 |
2020-04-01 |
Vertex Pharma |
Procedimiento para fabricar compuestos útiles como inhibidores de la quinasa ATR
|
US8765751B2
(en)
|
2011-09-30 |
2014-07-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
MX2014003785A
(es)
|
2011-09-30 |
2014-07-24 |
Vertex Phamaceuticals Inc |
Tratamiento del cancer de pancreas y del cancer de pulmon de celulas no pequeñas con inhibidores de atr.
|
US8853217B2
(en)
|
2011-09-30 |
2014-10-07 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
MX2014003796A
(es)
|
2011-09-30 |
2015-01-16 |
Vertex Pharma |
Compuestos utiles como inhibidores de la cinasa ataxia telangiectasia mutada y rad3 relacionados (atr).
|
CN103087050A
(zh)
*
|
2011-10-28 |
2013-05-08 |
山东轩竹医药科技有限公司 |
芳基激酶抑制剂
|
US8846917B2
(en)
|
2011-11-09 |
2014-09-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2013071093A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
WO2013071085A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2013071090A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
DE102011119127A1
(de)
|
2011-11-22 |
2013-05-23 |
Merck Patent Gmbh |
3-Cyanaryl-1H-pyrrolo[2.3-b]pyridin-Derivate
|
SI2810937T1
(sl)
*
|
2012-01-31 |
2017-01-31 |
Daiichi Sankyo Company, Limited |
Derivat piridona
|
JP6138831B2
(ja)
|
2012-02-09 |
2017-05-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
TBK1およびIKK阻害剤としてのフロ[3,2−b]−およびチエノ[3,2−b]ピリジン誘導体
|
WO2013148537A1
(en)
*
|
2012-03-29 |
2013-10-03 |
Ning Xi |
Substituted spirobicyclic compounds and methods of use
|
CA2869309C
(en)
|
2012-04-05 |
2021-02-09 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase and combination therapies thereof
|
US9096579B2
(en)
|
2012-04-20 |
2015-08-04 |
Boehringer Ingelheim International Gmbh |
Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
|
WO2013162061A1
(ja)
*
|
2012-04-26 |
2013-10-31 |
第一三共株式会社 |
二環性ピリミジン化合物
|
CA2876689C
(en)
|
2012-06-13 |
2022-04-26 |
Incyte Corporation |
Substituted tricyclic compounds as fgfr inhibitors
|
KR101245559B1
(ko)
*
|
2012-06-29 |
2013-03-22 |
한국화학연구원 |
신규 다중치환 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 이상세포 성장 질환의 예방 및 치료용 약학적 조성물
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
WO2014055756A1
(en)
|
2012-10-04 |
2014-04-10 |
Vertex Pharmaceuticals Incorporated |
Method for measuring atr inhibition mediated increases in dna damage
|
WO2014062604A1
(en)
|
2012-10-16 |
2014-04-24 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP3808749B1
(en)
|
2012-12-07 |
2023-03-08 |
Vertex Pharmaceuticals Incorporated |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
TWI498325B
(zh)
*
|
2013-01-18 |
2015-09-01 |
Hoffmann La Roche |
3-取代吡唑及其用途
|
EP2948447B1
(en)
|
2013-01-23 |
2016-09-21 |
Astrazeneca AB |
Chemical compounds
|
RU2671212C2
(ru)
*
|
2013-02-02 |
2018-10-30 |
Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд |
Замещенный 2-аминопиридин в качестве ингибитора протеинкиназы
|
EP2970311A4
(en)
|
2013-03-14 |
2016-11-23 |
Brigham & Womens Hospital |
BMP INHIBITORS AND METHODS OF USE
|
US9663519B2
(en)
|
2013-03-15 |
2017-05-30 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
HUE036571T2
(hu)
|
2013-04-19 |
2018-07-30 |
Incyte Holdings Corp |
Biciklusos heterociklusok mint FGFR inhibitorok
|
AU2014353006B2
(en)
|
2013-11-20 |
2019-04-04 |
Signalchem Life Sciences Corp. |
Quinazoline derivatives as TAM family kinase inhibitors
|
KR102398473B1
(ko)
|
2013-11-27 |
2022-05-16 |
시그널켐 라이프사이언시즈 코포레이션 |
Tam 패밀리 키나제 억제제로서의 아미노피리딘 유도체
|
HUE046727T2
(hu)
|
2013-12-06 |
2020-03-30 |
Vertex Pharma |
Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
|
EP3122355A4
(en)
*
|
2014-03-26 |
2017-08-09 |
The Brigham and Women's Hospital, Inc. |
Compositions and methods for inhibiting bmp
|
EP3134397A1
(en)
|
2014-04-24 |
2017-03-01 |
Novartis AG |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
MX2016013981A
(es)
|
2014-04-24 |
2016-11-15 |
Novartis Ag |
Derivados de amino-piridina como inhibidores de fosfatidil-inositol-3-cinasa.
|
BR112016023967A2
(pt)
*
|
2014-04-24 |
2017-08-15 |
Novartis Ag |
derivados de pirazina como inibidores de fosfatidilinositol 3-cinase
|
EP3152212B9
(en)
|
2014-06-05 |
2020-05-27 |
Vertex Pharmaceuticals Inc. |
Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof
|
JP6936007B2
(ja)
|
2014-06-17 |
2021-09-15 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Chk1阻害剤とatr阻害剤との組み合わせを使用してがんを処置する方法
|
TWI690525B
(zh)
|
2014-07-07 |
2020-04-11 |
日商第一三共股份有限公司 |
具有四氫吡喃基甲基之吡啶酮衍生物及其用途
|
US10513521B2
(en)
|
2014-07-15 |
2019-12-24 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for inhibiting BMP
|
US9359336B2
(en)
|
2014-10-09 |
2016-06-07 |
Allergan, Inc. |
Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
BR112017011671A2
(pt)
*
|
2014-12-02 |
2018-02-27 |
Bayer Cropscience Aktiengesellschaft |
compostos bicíclicos como agentes de controle de pragas.
|
JP6864953B2
(ja)
|
2014-12-09 |
2021-04-28 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Axlに対するヒトモノクローナル抗体
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
EP3259269B9
(en)
|
2015-02-20 |
2020-03-04 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
US9840503B2
(en)
|
2015-05-11 |
2017-12-12 |
Incyte Corporation |
Heterocyclic compounds and uses thereof
|
KR102647942B1
(ko)
|
2015-06-25 |
2024-03-14 |
다이호야쿠힌고교 가부시키가이샤 |
섬유증 치료제
|
US9708333B2
(en)
|
2015-08-12 |
2017-07-18 |
Incyte Corporation |
Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors
|
US10053465B2
(en)
|
2015-08-26 |
2018-08-21 |
Incyte Corporation |
Pyrrolopyrimidine derivatives as TAM inhibitors
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
TW201718581A
(zh)
|
2015-10-19 |
2017-06-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
SG10202004618TA
(en)
|
2015-11-19 |
2020-06-29 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
UA126113C2
(uk)
|
2015-12-22 |
2022-08-17 |
Інсайт Корпорейшн |
Гетероциклічні сполуки як імуномодулятори
|
EP3421039B1
(en)
|
2016-02-26 |
2021-10-06 |
ONO Pharmaceutical Co., Ltd. |
Drug for cancer therapy characterized by administering combination between axl inhibitor and immune checkpoint inhibitor
|
LT3436461T
(lt)
|
2016-03-28 |
2024-03-12 |
Incyte Corporation |
Pirolotriazino junginiai kaip tam inhibitoriai
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
ES2905980T3
(es)
|
2016-05-26 |
2022-04-12 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
CA3028685A1
(en)
|
2016-06-20 |
2017-12-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180016260A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018111049A1
(ko)
*
|
2016-12-15 |
2018-06-21 |
한국생명공학연구원 |
피리딘계 화합물을 유효성분으로 함유하는 dyrk 관련 질환의 예방 또는 치료용 약학적 조성물
|
KR102279347B1
(ko)
*
|
2016-12-15 |
2021-07-21 |
한국생명공학연구원 |
피리딘계 화합물을 유효성분으로 함유하는 dyrk 관련 질환의 예방 또는 치료용 약학적 조성물
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
AU2017382870B2
(en)
|
2016-12-22 |
2022-03-24 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
KR102323255B1
(ko)
|
2017-02-15 |
2021-11-08 |
다이호야쿠힌고교 가부시키가이샤 |
의약 조성물
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
JP7156287B2
(ja)
|
2017-08-23 |
2022-10-19 |
小野薬品工業株式会社 |
Axl阻害剤を有効成分として含むがん治療剤
|
AU2018342471B2
(en)
|
2017-09-27 |
2023-08-24 |
Incyte Corporation |
Salts of pyrrolotriazine derivatives useful as TAM inhibitors
|
US11826363B2
(en)
|
2017-10-13 |
2023-11-28 |
Ono Pharmaceutical Co., Ltd. |
Therapeutic agent for solid cancers, which comprises Axl inhibitor as active ingredient
|
US11174257B2
(en)
|
2018-05-04 |
2021-11-16 |
Incyte Corporation |
Salts of an FGFR inhibitor
|
CR20200590A
(es)
|
2018-05-04 |
2021-04-26 |
Incyte Corp |
Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
|
LT3790877T
(lt)
|
2018-05-11 |
2023-05-10 |
Incyte Corporation |
Tetrahidro-imidazo[4,5-c]piridino dariniai kaip pd-l1 imunomoduliatoriai
|
KR20210049088A
(ko)
|
2018-06-29 |
2021-05-04 |
인사이트 코포레이션 |
Axl/mer 억제제의 제형
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
KR102200032B1
(ko)
*
|
2019-03-13 |
2021-01-08 |
전남대학교산학협력단 |
호흡기 질환의 예방 또는 치료용 조성물
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
US11753406B2
(en)
|
2019-08-09 |
2023-09-12 |
Incyte Corporation |
Salts of a PD-1/PD-L1 inhibitor
|
KR20220075382A
(ko)
|
2019-09-30 |
2022-06-08 |
인사이트 코포레이션 |
면역조절제로서의 피리도[3,2-d]피리미딘 화합물
|
KR20220100879A
(ko)
|
2019-10-14 |
2022-07-18 |
인사이트 코포레이션 |
Fgfr 저해제로서의 이환식 헤테로사이클
|
WO2021076728A1
(en)
|
2019-10-16 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
EP4058461A1
(en)
|
2019-11-11 |
2022-09-21 |
Incyte Corporation |
Salts and crystalline forms of a pd-1/pd-l1 inhibitor
|
WO2021113479A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
CA3162010A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Derivatives of an fgfr inhibitor
|
WO2021146424A1
(en)
|
2020-01-15 |
2021-07-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
US11760756B2
(en)
|
2020-11-06 |
2023-09-19 |
Incyte Corporation |
Crystalline form of a PD-1/PD-L1 inhibitor
|
EP4240739A1
(en)
|
2020-11-06 |
2023-09-13 |
Incyte Corporation |
Process for making a pd-1/pd-l1 inhibitor and salts and crystalline forms thereof
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
AR126102A1
(es)
|
2021-06-09 |
2023-09-13 |
Incyte Corp |
Heterociclos tricíclicos como inhibidores de fgfr
|